ArticleJournal of gastrointestinal oncology2024

Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study.

Rong-Rong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.